Issue 1/2002
Content (10 Articles)
Doxorubicin-induced apoptosis and chemosensitivity in hepatoma cell lines
Terence Lee, Tracy Lau, Irene Ng
Blood and plasma pharmacokinetics of vinorelbine in elderly patients with advanced metastatic cancer
Amélie Gauvin, Frédéric Pinguet, Stéphane Culine, Cécile Astre, Didier Cupissol, Françoise Bressolle
Oral activity and pharmacokinetics of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice
Liangli Zhao, Philip Kestell, Lai-Ming Ching, Bruce C. Baguley
Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats
Merrill J. Egorin, Theodore F. Lagattuta, Deborah R. Hamburger, Joseph M. Covey, Kevin D. White, Steven M. Musser, Julie L. Eiseman
Atypical pharmacokinetics and excretion of new platinum analogues in rodents
Lorraine K. Webster, Andrew G. Ellis, Carmel Apicella, Glen B. Deacon
Pharmacokinetics of Bcl-2 antisense oligonucleotide (G3139) combined with doxorubicin in SCID mice bearing human breast cancer solid tumor xenografts
Daniel E. Lopes de Menezes, Lawrence D. Mayer
Antiangiogenic effects of a protein kinase Cβ-selective small molecule
Beverly A. Teicher, Enrique Alvarez, Krishna Menon, Michail A. Esterman, Eileen Considine, Chuan Shih, Margaret M. Faul
Enhanced antitumor activities of TZT-1027 against TNF-α or IL-6 secreting Lewis lung carcinoma in vivo
Tsugitaka Natsume, Yasuhiro Koh, Motohiro Kobayashi, Hisao Fukumoto, Fumiyuki Takahashi, Takashi Nakamura, Yuichiro Ohe, Nagahiro Saijo, Kazuto Nishio
A study of amsalog (CI-921) administered orally on a 5-day schedule, with bioavailability and pharmacokinetically guided dose escalation
D. Fyfe, F. Raynaud, R. Langley, D. Newell, G. Halbert, C. Gardner, K. Clayton, P. Woll, I. Judson, J. Carmichael
Phenylbutyrate-induced apoptosis is associated with inactivation of NF-κB IN HT-29 colon cancer cells
Rena Feinman, Kevin O. Clarke, Lawrence E. Harrison